Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

E1/E2/E3 Enzyme

Ubiquitin (UB) is a protein modifier that regulates many essential cellular processes. To initiate protein modification by UB, the E1 enzyme activates the C-terminal carboxylate of UB to launch its transfer through the E1-E2-E3 cascade onto target proteins. The E1 enzyme is the activating enzyme, to which ubiquitin is attached in an ATP-dependent reaction by a thioester bond. The E2 enzyme is the conjugating enzyme, to which the ubiquitin is transferred from the E1. The E3 is the ubiquitin ligase, which directly or indirectly catalyzes the transfer of the ubiquitin to the target protein (the substrate), with the formation of an isopeptide bond.

Pevonedistat
T6332905579-51-3
Pevonedistat (MLN4924) is a potent and selective NEDD8 activating enzyme (NAE) inhibitor (IC50=4.7 nM) with therapeutic potential for myelodysplastic syndromes (MDS) and antitumor activity.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
SAR405838
T65851303607-60-4In house
MI-773 (SAR405838 (MI 773)) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1.
  • $45
In Stock
Size
QTY
Cbl-b-IN-3
T637902573775-59-2In house
Cbl-b-IN-3 is a potent inhibitor of casitas b lineage lymphoma proto-oncogene-b (Cbl-b) (ic50 < 1 nM).
  • $383
In Stock
Size
QTY
2-D08
T7379144707-18-6
2-D08 is a synthetic flavone that inhibits sumoylation, also inhibits Axl with an IC50 of 0.49 nM.2-D08 showed anti-aggregatory and neuroprotective effect.
  • $52
In Stock
Size
QTY
TargetMol | Citations Cited
TAK-243
T169741450833-55-2
TAK-243 (MLN7243) is a selective inhibitor of the ubiquitin-activating enzyme UAE (IC50=1 nM), blocking ubiquitin binding and disrupting both mono-ubiquitin signaling and overall protein ubiquitination. TAK-243 exhibits antitumor activity and promotes apoptosis.
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
Subasumstat
T84281858276-04-6
Subasumstat (TAK-981), a selective inhibitor of the SUMOylation enzymatic cascade, has potential immune-activating and antineoplastic activities.
  • $76
In Stock
Size
QTY
Nutlin-3a
T6023675576-98-4
Nutlin-3a is the active enantiomer of Nutlin-3, an MDM2 antagonist that inhibits MDM2-p53 interaction (Ki=90 nM) and activates p53. Nutlin-3a binds preferentially to the p53-binding pocket of MDM2, leading to stabilization of p53 and activation of the p53 pathway. Nutlin-3a has antitumor activity.
  • $45
In Stock
Size
QTY
NSC232003
T122611905453-18-0
NSC232003 is a highly potent and cell-permeable inhibitor of [UHRF1].
  • $90
In Stock
Size
QTY
Nutlin-3
T2158548472-68-0
Nutlin-3 is an MDM2 antagonist that inhibits MDM2-p53 interaction (Ki=90 nM) and activates p53. Nutlin-3 binds preferentially to the p53-binding pocket of MDM2, leading to stabilization of p53 and activation of the p53 pathway. Nutlin-3 has antitumor activity.
  • $54
In Stock
Size
QTY
TargetMol | Citations Cited
Navtemadlin
TQ01271352066-68-2
Navtemadlin (AMG232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction (IC50: 0.6 nM). It binds to MDM2 with a Kd of 0.045 nM.
  • $67
In Stock
Size
QTY
TargetMol | Inhibitor Hot
ML-792
T161021644342-14-2
ML-792 is a specific small ubiquitin-like modifier activating enzyme (SUMO) inhibitor. ML-792 selectively inhibits SAE SUMO1 and SAE SUMO2 with IC50 of 3 and 11 nM.
  • $84
In Stock
Size
QTY
TargetMol | Citations Cited
Ginkgolic Acid
T6S212322910-60-7
Ginkgolic Acid (Romanicardic acid) C15:1 represses curli genes and prophage genes in EHEC.
  • $100
In Stock
Size
QTY
TargetMol | Citations Cited
Hinokiflavone
T4S018119202-36-9
Hinokiflavone, a novel modulator of pre-mRNA splicing activity both in vitro and in cellulo, inhibits the assembly of the spliceosome, particularly blocking the formation of the B complex. Additionally, it acts as a SUMO protease inhibitor by impeding the activity of sentrin-specific protease 1 (SENP1). Hinokiflavone also demonstrates significant cytotoxicity, including the inhibition of MMP-9.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
MD-224
T119802136247-12-4
MD-224 is a highly potent and efficacious MDM2 degrader based on the proteolysistargeting chimera (PROTAC) concept,and as a new class of anticancer agent.
  • $64
In Stock
Size
QTY
Mezigdomide
T107032259648-80-9In house
Mezigdomide (CC-92480) is a potent, novel, selective and active cereblon E3 ubiquitin ligase modulator (CELMoD) that acts as a molecular glue. Mezigdomide has anti-myeloma activity. [1]
  • $118
In Stock
Size
QTY
COH000
T51991534358-79-6
COH000 is a covalent and irreversible inhibitor of small ubiquitin-like modifier (SUMO)-activating enzyme and inhibited SUMOylation (IC50: ~ 0.2 μM in vitro).
  • $228
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Idasanutlin
T62541229705-06-9
Idasanutlin (Ro 5503781) (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
  • $34
In Stock
Size
QTY
TargetMol | Citations Cited
Avadomide
T35491015474-32-4
Avadomide (CC 122) is an orally available pleiotropic pathway modulator with potential antineoplastic activity.
  • $40
In Stock
Size
QTY
C25-140
T78891358099-18-9
C25-140 is a small-molecule inhibitor of TRAF6-Ubc13.
  • $68
In Stock
Size
QTY
TargetMol | Citations Cited
BC-1382
T85641013753-99-5
BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specifically disrupts the HECTD2 PIAS1 interaction(IC50 of 5 nM).
  • $91
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PRT4165
T311031083-55-3
PRT4165 (NSC600157) is a potent PRC1-mediated H2A ubiquitylation inhibitor.
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
WSB1 Degrader 1
T92362306039-66-5
WSB1 Degrader 1 is a potent, orally active degrader of WD repeat and SOCS box-containing 1, exhibiting anti-cancer metastatic effects.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BI8626
T145691875036-75-1
BI8626 is a ubiquitin ligase HUWE1 inhibitor with protective effects against spontaneous desiccation syndrome in NOD/ShiLtj mice.BI8626 inhibits intracellular cholesterol and decreases the expression of phosphorylated ZAP-70, CD25, and other activation markers, and inhibits the proliferation of CD4 T-cells.
  • $84
In Stock
Size
QTY
Siremadlin
T55551448867-41-1
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor.
  • $61
In Stock
Size
QTY
Heclin
T24136890605-54-6
Heclin is an inhibitor of HECT E3 ubiquitin ligase that acts by inhibiting Smurf2, Nedd4, and WWP1 with IC50 values of 6.8, 6.3, and 6.9 μM, respectively.
  • $39
In Stock
Size
QTY
RG7112
T6965939981-39-2
RG7112 (RO5045337) (RO5045337) is an orally bioavailable and selective p53-MDM2 inhibitor.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TAS4464 hydrochloride
T130901848959-11-4
TAS4464 hydrochloride is a highly potent and selective NEDD8 activating enzyme (NAE) inhibitor(IC50 of 0.955 nM).
  • $61
In Stock
Size
QTY
NAcM-OPT
T53742089293-61-6
NAcM-OPT is a specific, reversible inhibitor targeting N-Acetyl-UBE2M interaction with DCN1 (IC50: 79 nM).
  • $43
In Stock
Size
QTY
ZM223
T134122031177-48-5
ZM223 is an inhibitor of NEDD8 activating enzyme (NAE).
  • $117
In Stock
Size
QTY
SMIP004
T16901143360-00-3
SMIP004 is an SKP2 E3 ligase inhibitor. SMIP004 is a cancer cell-selective apoptosis inducer of human prostate cancer cells.
  • $82
In Stock
Size
QTY
BC1618
T89292222094-18-8
BC1618 (2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]-) is an orally active Fbxo48 inhibitor that stimulates Ampk-dependent signaling. It promotes mitochondrial fission, promotes autophagy and improves hepatic insulin sensitivity.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MX69
T36531005264-47-0
MX69 is the MDM2 XIAP inhibitor, blocking the MDM2 protein-XIAP RNA interaction, leading to MDM2 degradation.
  • $31
In Stock
Size
QTY
N106
T28124862974-25-2
N106 is an activator of the SUMO-activating enzyme, E1 ligase, and triggers intrinsic sumoylation of SERCA2a. N106 can be used in studies about heart failure.
  • $43
In Stock
Size
QTY
PYR-41
T6629418805-02-4
PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
SZL P1-41
T3317222716-34-9
SZL P1-41, a skp2 inhibitor, can prevent assembly of Skp2-Skp1 complexes. It selectively suppresses Skp2 SCF E3 ligase activity but exhibits no effect on the activity of other SCF complexes. It also inhibits Skp2-mediated p27 and Akt ubiquitination in vivo and in vitro. It suppresses the survival of Y cells and Y stem cells by triggering cell senescence and inhibiting glycolysis. It exhibits antitumor effects in multiple animal models and Y cell lines.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Serdemetan
T2243881202-45-5
Serdemetan (JNJ-26854165) is an orally bioavailable HDM2 antagonist with potential antineoplastic activity.
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Solasodine
T4036126-17-0
Solasodine (Purapuridine)(Purapuridine) is a poisonous alkaloid chemical compound that occurs in plants of the Solanaceae family. Solasodine showed selective cytotoxicity against cervical cancer cell line (HeLa) and human myeloid leukemia cell line (U937).
  • $68
In Stock
Size
QTY
NAE-IN-M22
T8816864420-54-2
NAE-IN-M22 (NEDD8 inhibitor M22) is a selective, potent and reversible inhibitor of NEDD8 activating enzyme (NAE). NAE-IN-M22 inhibits multiple cancer cell lines and induces apoptosis in A549 cells. NAE-IN-M22 also can inhibit tumor growth in vivo.
  • $93
In Stock
Size
QTY
TargetMol | Citations Cited
NVP-CGM097
TQ02311313363-54-0
NVP-CGM097 (CGM097) is an effective and specific MDM2 inhibitor (IC50: 1.7 nM for hMDM2).
  • $79
In Stock
Size
QTY
Skp2 Inhibitor C1
T4253432001-69-9
Skp2 Inhibitor C1 (SKPin C1)(SKPin C1) is a specific small molecule inhibitor of Skp2-mediated p27 degradation.
  • $36
In Stock
Size
QTY
TargetMol | Inhibitor Sale
SJ-172550
T16888431979-47-4
SJ-172550 is a small molecule inhibitor of MDMX (EC50: 5 μM).
  • $37
In Stock
Size
QTY
BH3I-1
T1493300817-68-9
BH3I-1 (BHI1) is a Bcl-2 antagonist.
  • $30
In Stock
Size
QTY
DKM 2-93
T741565836-72-8
DKM 2-93 is a relatively selective inhibitor of UBA5 (IC50: 430 μM).
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
RO8994
T35171309684-94-3
RO8994 is a highly effective and specific inhibitor of spiroindolinone small-molecule MDM2, with IC50 of 20 nM (MTT proliferation assays) and 5 nM (HTRF binding assays).
  • $34
In Stock
Size
QTY
NSC697923
T6611343351-67-7In house
NSC-697923 (2-[(4-methylphenyl)sulfonyl]-5-nitrofuran), a potent inhibitor of UBE2N (ubiquitin-conjugating enzyme E2 N, Ubc13), exhibits its role in inducing cell death in neuroblastoma (NB) cells through two distinct mechanisms. In p53 wild-type NB cells, NSC-697923 promotes the nuclear importation of p53, thereby triggering cell death. Meanwhile, in p53 mutant NB cells, NSC-697923 activates the JNK-mediated apoptotic pathway, leading to cell death. Additionally, NSC-697923 inhibits DNA damage and NF-κB signaling, further contributing to its antitumor activity.
  • $39
In Stock
Size
QTY
WS-383
T133492247544-02-9
WS-383 is a selective, potent and reversible DCN1-UBC12 interaction inhibitor(IC50 of 11 nM).
  • $38
In Stock
Size
QTY
PYZD-4409
T16699423148-78-1
PYZD-4409 is a selective UBA1 inhibitor with an IC50 of 20 μM. PYZD-4409 induces cell death in malignant cells and is preferentially cytotoxic to malignant cells over normal hematopoietic cells.
  • $32
In Stock
Size
QTY
GS143
T25465916232-21-8
GS143 is a selective IκBα ubiquitination inhibitor with an IC50 of 5.2 μM for SCFβTrCP1-mediated IκBα ubiquitylation. It suppresses NF-κB activation and transcription of target genes without inhibiting proteasome activity. GS143 has anti-asthm[atic] properties.
  • $32
In Stock
Size
QTY
TargetMol | Inhibitor Sale